Results 141 to 150 of about 192,514 (206)

Optimization of untranslated regions enhances antigen expression and immunogenicity of FMDV P12A3C mRNA vaccine. [PDF]

Virol J
Liu H, Mehdi MM, Jiang L, Liu Y, Ma Y, Teng Z, Liang B, Guo H, Sun S.   +8 more
europepmc   +1 more source

Advancements and challenges in next-generation mRNA vaccine manufacturing systems. [PDF]

Clin Exp Vaccine Res
Seo SH, Song MK.
europepmc   +1 more source

Influenza mRNA vaccine reduces pathogenicity and transmission of A(H5N1) virus in a ferret model. [PDF]

NPJ Vaccines
Hatta M, Brock N, Hauguel T, Feng C, Huang Y, Ritter JM, Hatta Y, Keller MW, De Souza I, Hossain J, Pusch EA, Rowe T, Zhang H, Cui L, O'Leary S, De La Cruz JA, Johnson MC, Belser JA, Sun X, Liddell J, Creech M, Rouse JR, Carney P, Chang J, Currier M, Wang L, Kirby MK, Di H, Barnes JR, Stevens J, Dugan VG, Davis CT, Wentworth DE, Allen PS, Maines TR, Zhou B.   +35 more
europepmc   +1 more source

Multigenic single-chain mRNA vaccine provides full protection against <i>Dabie bandavirus</i> infection. [PDF]

Mol Ther Nucleic Acids
Costa da Silva GH, Carvalho Costa PA, Pires Goulart Guimarães P.   +2 more
europepmc   +1 more source

A VLP-based mRNA vaccine elicits potent humoral and cellular immunity against Oropouche virus. [PDF]

mBio
Shi Y, Zhang G, Lin S, Hu M, Wang Y, Ge H, Xia S, Wang Q, Jiang S, Lu L.   +9 more
europepmc   +1 more source

Clinical Serum-Anchored Computational Design Pipeline for a Broad-Spectrum Influenza Multi-Epitope mRNA Vaccine. [PDF]

Biology (Basel)
Yuan L, Ouyang Z, Zhao Y, Bi R, Wu Y, Li X, Li Y, Song J, Li W, Yan M, Wen S, Luo H, Bai T, Shu Y, Chen Y.   +14 more
europepmc   +1 more source

An engineered linear cap-independent mRNA vaccine with intrinsic adjuvanticity induces potent anti-tumor immunity in mice. [PDF]

Nat Commun
Yu H, Yang Y, Lin P, Liu C, Wen Y, Huang Z, Fang Z, Hu Z, Huang S.   +8 more
europepmc   +1 more source

Type I interferon restricts mRNA vaccine efficacy through suppression of antigen uptake in cDCs. [PDF]

NPJ Vaccines
Lobb TA, Dickson A, Guo W, Beeram S, Carrero JA, Dalben Y, DiPaolo RJ, Alspach E, Tse LV, Ferris ST.   +9 more
europepmc   +1 more source

Engineering of mRNA vaccine platform with reduced lipids and enhanced efficacy. [PDF]

Nat Commun
Ma X, Liu S, Zhang S, Liu Z, Wang H, Luo W, Zu M, Qin H, Li Z, Zhong J, Li J, Chen Q, Lin J, Liu A, Zhang X, Li H, Lu X, Shi X, Li L, Gu Z, Nie G, Ji T.   +21 more
europepmc   +1 more source